Edition:
United States

Trinity Biotech PLC (TRIB.OQ)

TRIB.OQ on NASDAQ Stock Exchange Global Select Market

4.81USD
23 Apr 2018
Change (% chg)

$-0.19 (-3.80%)
Prev Close
$5.00
Open
$4.98
Day's High
$4.98
Day's Low
$4.81
Volume
5,609
Avg. Vol
7,263
52-wk High
$6.47
52-wk Low
$4.30

Chart for

About

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the... (more)

Overall

Beta: 1.33
Market Cap(Mil.): $120.20
Shares Outstanding(Mil.): 24.04
Dividend: --
Yield (%): --

Financials

  TRIB.OQ Industry Sector
P/E (TTM): 7.58 30.21 32.78
EPS (TTM): 0.64 -- --
ROI: 2.01 13.61 13.21
ROE: 4.56 15.28 15.01

BRIEF-Trinity Biotech reports Q3 earnings per share $0.063

* Q3 revenue $25.6 million versus I/B/E/S view $26.1 million Source text for Eikon: Further company coverage:

Oct 26 2017

Competitors

  Price Chg
Tosoh Corporation (4042.T) ¥2,014 --
Siemens AG (SIEGn.DE) €108.48 +0.18
Johnson & Johnson (JNJ.N) $126.83 +0.17
Roche Holding Ltd. (ROG.S) CHF217.60 +1.95
Roche Holding Ltd. (RO.S) CHF221.40 +1.40
Abbott Laboratories (ABT.N) $58.84 -0.35
Bayer AG (BAYGn.DE) €98.79 -0.21
Bayer AG (BAYE.F) -- --
Thermo Fisher Scientific Inc. (TMO.N) $216.35 +0.46
Alere Inc (ALR) 71.50zł -1.35

Earnings vs. Estimates